共 50 条
Percutaneous intervention versus coronary artery bypass graft surgery in left main coronary artery stenosis: a systematic review and meta-analysis
被引:23
|作者:
Zhang, Xin-Lin
[1
]
Zhu, Qing-Qing
[2
]
Yang, Jing-Jing
[3
]
Chen, Yu-Han
[1
]
Li, Yang
[1
]
Zhu, Su-Hui
[1
]
Xie, Jun
[1
]
Wang, Lian
[1
]
Kang, Li-Na
[1
]
Xu, Biao
[1
]
机构:
[1] Nanjing Univ, Sch Med, Affiliated Drum Tower Hosp, Dept Cardiol, 321 Zhongshan Rd, Nanjing 210008, Jiangsu, Peoples R China
[2] Nanjing Univ, Jinling Hosp, Dept Resp Med, Sch Med, Nanjing, Jiangsu, Peoples R China
[3] Nanjing Univ Chinese Med, Clin Coll Tradit Chinese & Western Med, Nanjing Drum Tower Hosp, Dept Tradit Chinese Med, Nanjing, Jiangsu, Peoples R China
来源:
BMC MEDICINE
|
2017年
/
15卷
基金:
中国国家自然科学基金;
关键词:
Left main coronary artery disease;
Percutaneous coronary intervention;
Coronary artery bypass graft surgery;
Meta-analysis;
Randomized controlled trials;
Matched observational studies;
DRUG-ELUTING STENT;
LONG-TERM OUTCOMES;
5-YEAR OUTCOMES;
UPDATED METAANALYSIS;
RANDOMIZED-TRIALS;
DISEASE;
REVASCULARIZATION;
IMPLANTATION;
REGISTRY;
SYNERGY;
D O I:
10.1186/s12916-017-0853-1
中图分类号:
R5 [内科学];
学科分类号:
1002 ;
100201 ;
摘要:
Background: The optimal revascularization technique in patients with left main coronary artery disease (CAD) remains controversial. We aimed to compare the long-term performance of percutaneous coronary intervention (PCI) versus coronary artery bypass graft (CABG) surgery in treatment of left main CAD. Methods: PubMed, EMBASE, and the Cochrane Library were searched until November 16, 2016. Results: Six randomized controlled trials and 22 matched observational studies including 22,487 patients and 90,167 patient-years of follow-up were included. PCI was associated with an overall higher risk for the major adverse cardiac and cerebrovascular events (hazard ratio (HR), 1.42; 95% confidence interval (CI), 1.14-1.77), mainly driven by higher rates of myocardial infarction (HR, 1.69; 95% CI, 1.22-2.34) and revascularization (HR, 2.80; 95% CI, 1.86-4.22). The overall risks for all-cause death (HR, 1.05; 95% CI, 0.93-1.20), cardiac death (HR, 1.05; 95% CI, 0.69-1.59), stroke (HR, 0.64; 95% CI, 0.33-1.24), and the composite safety endpoint of death, myocardial infarction, or stroke (HR, 1.06; 95% CI, 0.97-1.16) were similar between PCI and CABG. Stratified analysis based on stent types showed that the increased risk for myocardial infarction associated with PCI was only evident in patients with bare-metal stents or early-generation drug-eluting stents (DES), but not newer-generation DES. Stratified analyses based on study designs showed largely similar findings with the overall analyses, except for a significantly higher incidence of myocardial infarction in adjusted studies (HR, 2.01; 95% CI, 1.64-2.45) but a trend toward higher incidence in randomized trials (HR, 1.39; 95% CI, 0.85-2.27) associated with PCI. Conclusions: Compared with CABG, PCI with newer-generation DES might be a safe alternative revascularization strategy for treatment of left main CAD, but is associated with more repeat revascularization.
引用
收藏
页数:14
相关论文